Short answer
Amphastar Pharmaceuticals, Inc. (AMPH) filed an 8-K current report with the SEC on March 6, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Liawatidewi (EVP Corporate Admin, Secretary, Board member): $525,800 base salary + 55% target bonus.
Amphastar Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Liawatidewi (EVP Corporate Admin, Secretary, Board member): $525,800 base salary + 55% target bonus
- Zhou (Sr. EVP Production): $590,000 base salary + 53% target bonus
- Severance on qualifying termination: 2x (highest base salary + avg 2-year bonus) plus 12 months health coverage and 100% equity acceleration
- Change-in-control double-trigger adds another 2x cash lump sum and additional 12 months health premiums on top of standard severance
- Full equity acceleration triggered by change-in-control alone, regardless of termination: notable shareholder dilution risk in M&A scenarios
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Amphastar Pharmaceuticals, Inc. 8-K filings
Get the next AMPH 8-K as it lands
Follow AMPH for push alerts, or ask the research agent what this filing means.